Items Tagged ‘ovarian cancer’
June 3, 2019
Identifying hereditary cancer risk: genetic testing can lead to better screening, earlier treatment
By Sharon Rosen 
Do you have family members who have been diagnosed with gastrointestinal, breast or ovarian cancer? According to a recent Mayo Clinic study, nearly 5% to 10% of these cancers can be hereditary. That’s why it is important to share your family medical history with your physician, who can determine if you and your family members […]
Tags: #cancer risk, #Center for Individualized Mediicine, #gastrointestinal cancer, breast cancer, colorectal cancer, Dr. Niloy "Jewel" Samadder, Genetic Testing, genomics, hereditary cancer, lynch syndrome, mayo clinic, Mayo Clinic Proceedings
August 27, 2018
Gerstner awards boost research into hereditary cancer, Parkinson’s disease
Creating tools to detect cancer at an early stage and advancing research into the genetic links to Parkinson’s disease are focuses of the 2018 Gerstner Family Career Development Awards. This year’s winners are Niloy ‘Jewel’ Samadder, M.D., a gastroenterologist at Mayo’s Arizona campus whose research focuses on inherited cancer, and Fabienne Fiesel, Ph.D., a neurosciences […]
Tags: #Parkinson's disease, breast cancer, colon cancer, Dr. Niloy "Jewel" Samadder, Gertsner Family Career Development Awards, hereditary cancer, Mayo Clinic Center for Individualized Medicine, ovarian cancer, Pancreatic Cancer
July 21, 2016
Liquid Biopsies Offer Hope for Earlier Treatment, Better Tracking of Ovarian Cancer
By Sharon Rosen
Ovarian cancer has long been one of the trickiest forms of cancer to diagnose and treat. It often goes unnoticed until the late stages. For most women, the cancer goes into remission after the first round of treatment but then returns with a vengeance. Three-quarters of the time, ovarian cancer comes back with a tumor […]
Tags: center for individualized medicine, diagnostic, Dr. George Vasmatzis, early detection for ovarian cancer, Liquid biopsy, mate-pair sequencing, mayo clinic, medical research, ovarian cancer, whole genome sequencing